OZACTIN O3G Trademark

Trademark Overview

On Monday, March 31, 2025, a trademark application was filed for OZACTIN O3G with the United States Patent and Trademark Office. The USPTO has given the OZACTIN O3G trademark a serial number of 99113251. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 31, 2025. The OZACTIN O3G trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary preparations for horses for the treatment and prevention of Arthritis, Neurologic Disease, Laminitis/Founder, Metabolic Disease, Degenerative Suspensory Ligament Desmitis, Anhidrosis, Chronic Pain, and Performance issues; Veterinary preparations for dogs for the treatment and prevention of Arthritis, Neurologic Disease, Laminitis/Founder, Metabolic Disease, Degenerative Suspensory Ligament Desmitis, Anhidrosis, Chronic Pain, and Performance issues; Medicinal preparations for the treatment and prevention of Arthritis, Neurologic Disease, Laminitis/Founder, Metabolic Disease, Degenerative Suspensory Ligament Desmitis, Anhidrosis, Chronic Pain, and Performance issues; Nutritional supplements consisting primarily of ozonated glycerin; Therapeutic pharmaceutical for the treatment of Arthritis, Neurologic Disease, Laminitis/Founder, Metabolic Disease, Degenerative Suspensory Ligament Desmitis, Anhidrosis, Chronic Pain, and Performance issues in horses, dogs, and humans, namely, t...
ozactin o3g

General Information

Serial Number99113251
Word MarkOZACTIN O3G
Filing DateMonday, March 31, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, March 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesVeterinary preparations for horses for the treatment and prevention of Arthritis, Neurologic Disease, Laminitis/Founder, Metabolic Disease, Degenerative Suspensory Ligament Desmitis, Anhidrosis, Chronic Pain, and Performance issues; Veterinary preparations for dogs for the treatment and prevention of Arthritis, Neurologic Disease, Laminitis/Founder, Metabolic Disease, Degenerative Suspensory Ligament Desmitis, Anhidrosis, Chronic Pain, and Performance issues; Medicinal preparations for the treatment and prevention of Arthritis, Neurologic Disease, Laminitis/Founder, Metabolic Disease, Degenerative Suspensory Ligament Desmitis, Anhidrosis, Chronic Pain, and Performance issues; Nutritional supplements consisting primarily of ozonated glycerin; Therapeutic pharmaceutical for the treatment of Arthritis, Neurologic Disease, Laminitis/Founder, Metabolic Disease, Degenerative Suspensory Ligament Desmitis, Anhidrosis, Chronic Pain, and Performance issues in horses, dogs, and humans, namely, therapeutic sprays and injectables containing ozonated glycerin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 31, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressAubrey, TX 76227
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressOak Point, TX 75068

Trademark Events

Event DateEvent Description
Monday, March 31, 2025NEW APPLICATION ENTERED
Monday, March 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 31, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

ozactin disease ligament suspensory degenerative desmitis chronic issues performance pain metabolic